These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28187014)

  • 1. Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance.
    Xie Y; Wu Y; Xin K; Wang JJ; Xu H; Ildstad ST; Leventhal J; Yang GY; Zhang Z; Levitsky J
    Transplantation; 2017 May; 101(5):1056-1066. PubMed ID: 28187014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
    Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK
    Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.
    Xu H; Ramsey DM; Wu S; Bozulic LD; Ildstad ST
    Transplantation; 2013 Jan; 95(2):301-8. PubMed ID: 23250336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.
    Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M
    Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1/Th2 balance in rat heterotopic small bowel transplantation.
    Hu A; Li Q; Shi H; Tai Q; Wu L; Xiong J; Fu B; He X
    Dig Liver Dis; 2012 Dec; 44(12):988-94. PubMed ID: 22954489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
    Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
    Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.
    Chaudhry S; Kato Y; Weiner J; Alonso-Guallart P; Baker S; Woodland DC; Lefkowitch JH; Duran-Struuck R; Sondermeijer HP; Zitsman J; Sears ML; Wu A; Karolewski B; Houck PJ; Martinez M; Kato T; Sykes M; Griesemer AD
    Transplantation; 2020 Aug; 104(8):1580-1590. PubMed ID: 32732835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
    Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
    J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.
    Rahhal DN; Xu H; Huang WC; Wu S; Wen Y; Huang Y; Ildstad ST
    Transplantation; 2009 Sep; 88(6):773-81. PubMed ID: 19920776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.